DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Excelsoft Technologies Limited — Updates

NSE 2 hrs ago·4 Sept 2026, 1:35 pm

Excelsoft Technologies L

Excelsoft Technologies Limited has informed stock exchanges that it is complying with SEBI's Regulation 7(2) regarding the reporting of insider trading disclosures. This regulation mandates that companies promptly disclose any trades made by their designated insiders, such as directors and key managerial personnel, within a specific timeframe.

For investors, this update is a routine compliance measure. It ensures transparency regarding the trading activities of company insiders, which can be a useful indicator of management's confidence in the firm's future prospects. It does not signal any new financial developments or operational changes.

Investors should continue to focus on the company's core business performance and quarterly results. This regulatory filing is a standard procedural update and does not alter the fundamental outlook for the stock.